By Sabela Ojea

iBio Inc. on Thursday disclosed that the MUC16 protein is the target of its latest immune-oncology program. Shares surged 129% in after-hours trading.

DoorDash Inc. reported a 40% rise in revenue in its latest quarter, as consumers spent more on deliveries of food and household essentials even as prices rose and more restaurants reopened. Shares climbed 5.6% in after-hours trading.

DraftKings Inc. raised its fiscal-year 2023 guidance after reporting a surge in fourth-quarter revenue. Shares of the online sports-betting company increased 5.1% in after-hours trading.

Moderna Inc. posted mixed results for an experimental Moderna vaccine against seasonal influenza in a clinical trial of more than 6,100 adults in the southern hemisphere. Shares of the pharmaceutical company edged down 5.9% in after-hours trading.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

February 16, 2023 18:49 ET (23:49 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Moderna.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Moderna.